Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

被引:439
作者
Pestka, Jan M.
Zeisel, Mirjam B.
Blaeser, Edith
Schuermann, Peter
Bartosch, Birke
Cosset, Francois-Loic
Patel, Arvind H.
Meisel, Helga
Baumert, Jens
Viazov, Sergei
Rispeter, Kay
Blum, Hubert E.
Roggendorf, Michael
Baumert, Thomas F. [1 ]
机构
[1] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany
[2] Ecole Normale Super Lyon, F-69364 Lyon, France
[3] INSERM, F-69364 Lyon, France
[4] Univ Glasgow, Inst Virol, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland
[5] Humboldt Univ, Inst Virol, Charite, D-10117 Berlin, Germany
[6] GSF, Inst Epidemiol, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany
[7] Univ Essen Gesamthsch, Inst Virol, D-45122 Essen, Germany
[8] INSERM, U748, F-67000 Strasbourg, France
[9] Univ Strasbourg, F-67000 Strasbourg, France
[10] Hop Univ Strasbourg, Serv Hepatogastroenterol, F-67000 Strasbourg, France
基金
英国医学研究理事会;
关键词
vaccines; pathogenesis; host reponses;
D O I
10.1073/pnas.0607026104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In contrast to a detailed understanding of antiviral cellular immune responses, the impact of neutralizing antibodies for the resolution of acute hepatitis C is poorly defined. The analysis of neutralizing responses has been hampered by the fact that patient cohorts as well as hepatitis C virus (HCV) strains are usually heterogeneous, and that clinical data from acute-phase and long-term follow-up after infection are not readily available. Using an infectious retroviral HCV pseucloparticle model system, we studied a cohort of women accidentally exposed to the same HCV strain of known sequence. In this single-source outbreak of hepatitis C, viral clearance was associated with a rapid induction of neutralizing antibodies in the early phase of infection. Neutralizing antibodies decreased or disappeared after recovery from HCV infection. In contrast, chronic HCV infection was characterized by absent or low-titer neutralizing antibodies in the early phase of infection and the persistence of infection despite the induction of cross-neutralizing antibodies in the late phase of infection. These data suggest that rapid induction of neutralizing antibodies during the early phase of infection may contribute to control of HCV infection. This finding may have important implications for understanding the pathogenesis of HCV infection and for the development of novel preventive and therapeutic antiviral strategies.
引用
收藏
页码:6025 / 6030
页数:6
相关论文
共 43 条
[1]   HCV natural history: The retrospective and prospective in perspective [J].
Alter, HJ .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :550-552
[2]   Uptake and presentation of hepatitis C virus-like particles by human dendritic cells [J].
Barth, H ;
Ulsenheimer, A ;
Pape, GR ;
Diepolder, HM ;
Hoffmann, M ;
Neumann-Haefelin, C ;
Thimme, R ;
Henneke, P ;
Klein, R ;
Paranhos-Baccalà, G ;
Depla, E ;
Liang, TJ ;
Blum, HE ;
Baumert, TF .
BLOOD, 2005, 105 (09) :3605-3614
[3]   Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes [J].
Barth, H ;
Cerino, R ;
Arcuri, M ;
Hoffmann, M ;
Schürmann, P ;
Adah, MI ;
Gissler, B ;
Zhao, XP ;
Ghisetti, V ;
Lavezzo, B ;
Blum, HE ;
von Weizsäcker, F ;
Vitelli, A ;
Scarselli, E ;
Baumert, TF .
JOURNAL OF VIROLOGY, 2005, 79 (09) :5774-5785
[4]   Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate [J].
Barth, H ;
Schäfer, C ;
Adah, MI ;
Zhang, FM ;
Linhardt, RJ ;
Toyoda, H ;
Kinoshita-Toyoda, A ;
Toida, T ;
van Kuppevelt, TH ;
Depla, E ;
von Weizsäcker, F ;
Blum, HE ;
Baumert, TF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :41003-41012
[5]   Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction [J].
Barth, Heidi ;
Schnober, Eva K. ;
Zhang, Fuming ;
Linhardt, Robert J. ;
Depla, Erik ;
Boson, Bertrand ;
Cosset, Francois-Loic ;
Patel, Arvind H. ;
Blum, Hubert E. ;
Baumert, Thomas F. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10579-10590
[6]   Hepatitis C virus entry: Molecular biology and clinical implications [J].
Barth, Heidi ;
Liang, T. Jake ;
Baumert, Thomas F. .
HEPATOLOGY, 2006, 44 (03) :527-535
[7]   An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies [J].
Bartosch, B ;
Verney, G ;
Dreux, M ;
Donot, P ;
Morice, Y ;
Penin, F ;
Pawlotsky, JM ;
Lavillette, D ;
Cosset, FL .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8217-8229
[8]   In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes [J].
Bartosch, B ;
Bukh, J ;
Meunier, JC ;
Granier, C ;
Engle, RE ;
Blackwelder, WC ;
Emerson, SU ;
Cosset, FL ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14199-14204
[9]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[10]   Adaptive immune responses in acute and chronic hepatitis C virus infection [J].
Bowen, DG ;
Walker, CM .
NATURE, 2005, 436 (7053) :946-952